Literature DB >> 21447621

Fulvestrant for advanced male breast cancer patients: a case series.

G Masci1, C Gandini2, M Zuradelli2, P Pedrazzoli2, R Torrisi2, F R Lutman3, A Santoro2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447621     DOI: 10.1093/annonc/mdr005

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.

Authors:  Giovanna Masci; Michele Caruso; Francesco Caruso; Piermario Salvini; Carlo Carnaghi; Laura Giordano; Vittoria Miserocchi; Agnese Losurdo; Monica Zuradelli; Rosalba Torrisi; Luca Di Tommaso; Corrado Tinterri; Alberto Testori; Carlos A Garcia-Etienne; Wolfgang Gatzemeier; Armando Santoro
Journal:  Oncologist       Date:  2015-05-06

Review 2.  Male breast carcinoma: increased awareness needed.

Authors:  Jonathan White; Olive Kearins; David Dodwell; Kieran Horgan; Andrew M Hanby; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2011-09-29       Impact factor: 6.466

3.  Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer.

Authors:  Hang Jiang; Tao Wang; Zefei Jiang
Journal:  World J Surg Oncol       Date:  2014-12-23       Impact factor: 2.754

Review 4.  Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.

Authors:  Andrea Rocca; Roberta Maltoni; Sara Bravaccini; Caterina Donati; Daniele Andreis
Journal:  Cancer Manag Res       Date:  2018-08-30       Impact factor: 3.989

5.  Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.

Authors:  F Zagouri; T N Sergentanis; V Koutoulidis; C Sparber; G G Steger; P Dubsky; G C Zografos; T Psaltopoulou; M Gnant; M-A Dimopoulos; R Bartsch
Journal:  Br J Cancer       Date:  2013-05-30       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.